1. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors. Issue 5 (26th October 2021) Authors: Satomi, Kaishi; Takami, Hirokazu; Fukushima, Shintaro; Yamashita, Satoshi; Matsushita, Yuko; Nakazato, Yoichi; Suzuki, Tomonari; Tanaka, Shota; Mukasa, Akitake; Saito, Nobuhito; Kanamori, Masayuki; Kumabe, Toshihiro; Tominaga, Teiji; Kobayashi, Keiichi; Nagane, Motoo; Iuchi, Toshihiko; Yoshimoto,... Journal: Neuro-oncology Issue: Volume 24:Issue 5(2022) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma. Issue 3 (30th November 2018) Authors: Narita, Yoshitaka; Arakawa, Yoshiki; Yamasaki, Fumiyuki; Nishikawa, Ryo; Aoki, Tomokazu; Kanamori, Masayuki; Nagane, Motoo; Kumabe, Toshihiro; Hirose, Yuichi; Ichikawa, Tomotsugu; Kobayashi, Hiroyuki; Fujimaki, Takamitsu; Goto, Hisaharu; Takeshima, Hideo; Ueba, Tetsuya; Abe, Hiroshi; Tamiya, Taka... Journal: Neuro-oncology Issue: Volume 21:Issue 3(2019) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACT-15 EFFICACY AND SAFETY OF SUBTOTAL RESECTION, 'FLAIRECTOMY' FOR RECURRENT GLIOBLASTOMA. (3rd December 2022) Authors: Saito, Kuniaki; Sasaki, Nobuyoshi; Sasaki, Yuta; Yamagishi, Yuki; Kobayashi, Keiichi; Shiokawa, Yoshiaki; Nakatomi, Hirofumi; Nagane, Motoo Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACT-19 A REPORT OF PHASE I PART OF PHASE I/II STUDY OF MAINTENANCE THERAPY WITH METFORMIN AND TEMOZOLOMIDE FOR GLIOBLASTOMA. (3rd December 2022) Authors: Ohno, Makoto; Kitanaka, Chifumi; Miyakita, Yasuji; Tanaka, Shota; Takahashi, Masamichi; Yanagisawa, Shunsuke; Sonoda, Yukihiko; Matsuda, Kenichiro; Mishima, Kazuhiko; Suzuki, Tomonari; Shirahara, Mitsuaki; Ishikawa, Eiichi; Ohashi, Ken; Nagane, Motoo; Narita, Yoshitaka Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS. (11th November 2019) Authors: Ichimura, Koichi; Nagane, Motoo; Kato, Mamoru; Narita, Yoshitaka; Aoki, Tomokazu; Tanaka, Shota; Mukasa, Akitake; Wakabayashi, Toshihiko; Uzuka, Takeo; Nakamura, Hideo; Arakawa, Yoshiki; Suehiro, Satoshi; Nakada, Mitsutoshi; Kitahara, Mai; Hibiya, Yuko; Narushima, Daichi; Onuki, Ritsuko; Morita, ... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ACTR-48. FEASIBILITY OF DISCONTINUATION OF ADJUVANT TEMOZOLOMIDE AFTER 12 CYCLES REMAINING WITHOUT PROGRESSION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (5th November 2018) Authors: Nagane, Motoo; Kobayashi, Keiichi; Saito, Kuniaki; Shimizu, Saki; Suematsu, Shinya; Kume, Satoshi; Okamura, Yuma; Shiokawa, Yoshiaki Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BIOM-27. PROGNOSTIC SIGNIFICANCE OF EXTENT OF RESECTION IN GLIOMA ACCORDING TO THE 2021 WHO CLASSIFICATION. (14th November 2022) Authors: Saito, Kuniaki; Sasaki, Yuta; Shimizu, Saki; Nagai, Jun; Yamagishi, Yuki; Sasaki, Nobuyoshi; Kobayashi, Keiichi; Shiokawa, Yoshiaki; Nakatomi, Hirofumi; Nagane, Motoo Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BOT-3 Prognostic Factors of CNS Germ Cell Tumors; Molecular and Histopathological Analyses on 154 Cases from the iGCT Consortium. (6th December 2021) Authors: Takami, Hirokazu; Satomi, Kaishi; Fukuoka, Kohei; Matsushita, Yuko; Yamasaki, Kai; Nakamura, Taishi; Kanamori, Masayuki; Tominaga, Teiji; Tanaka, Shota; Mukasa, Akitake; Saito, Nobuhito; Suzuki, Tomonari; Yanagisawa, Takaaki; Nakamura, Hideo; Sakai, Keiichi; Sugiyama, Kazuhiko; Tamura, Kaoru; Mae... Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 6 Page Start: vi8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BT-09 CLINICAL AND MOLECULAR GENETIC FEATURE OF CEREBELLAR GLIOBLASTOMA. (16th December 2019) Authors: Iijima, Shohei; Saito, Kuniaki; Shimizu, Saki; Kobayashi, Keiichi; Shimada, Daisuke; Matsumoto, Yoshie; Shiokawa, Yoshiaki; Nagane, Motoo Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BT-4 PROGNOSIS OF HISTOLOGICALLY DIAGNOSED GRADE 2-3 IDH-WILD TYPE DIFFUSE GLIOMAS TREATED WITH RADIATION AND TEMOZOLOMIDE. (3rd December 2022) Authors: Arita, Hideyuki; Takayangi, Shunsaku; Tanaka, Shota; Nakamura, Taishi; Shirahata, Mitsuaki; Tamura, Kaoru; Uduka, Takeo; Nagane, Motoo; Narita, Yoshitaka; Ichimura, Koichi Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗